Masami Hasegawa

Tokyo Medical and Dental University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

71h-index31.2kcitations314works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics and Phylogenetic Studies(77), Genetic diversity and population structure(59), Evolution and Paleontology Studies(39), Amphibian and Reptile Biology(34), Animal Behavior and Reproduction(23)

Publications313 total

Anesthetic Management of a Dental Patient With Familial Mediterranean Fever
Anesthesia Progress·2025Open Access
Habitat use and abundance of an introduced population of the Japanese weasel (Mustela itatsi): Comparison with the native population
PLoS ONE·2025Open Access
Comparing the effect of land use on the abundance of two arboreal frog species in rice paddy landscapes with varying forest coverage
Landscape and Ecological Engineering·2024
Abstract 1654: Anti-tumor activity of orally-available cyclic peptide LUNA18 through direct RAS inhibition in RAS-altered tumors
Cancer Research·2024· 5 cited
Abstract 1664: Combination of LUNA18, a novel RAS inhibitor, with KRAS G12C inhibitors augments anti-tumor activity via inhibition of MAPK pathway reactivation
Cancer Research·2024· 2 cited
Current situation and challenges for Japanese business sector toward Nature Positive
Journal of The Japanese Institute of Landscape Architecture·2024Open Access
The effect of pioneer carrion beetles on the emission of volatile organic compounds and carrion insect community assembly
Ecology and Evolution·2023· 6 citedOpen Access
Giant Snakes and Tiny Seabirds on a Small Japanese Island
2023· 1 cited
Evaluation of the host specificity of Eimeria uekii and Eimeria raichoi for Japanese rock ptarmigans by oocyst transfer to taxonomically related birds
Parasitology Research·2023· 1 cited
Table S1 from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Table S1 from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Figures S1-5 & Tables S2-5 from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Figures S1-5 & Tables S2-5 from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
2023Open Access
Supplementary Table S1 from YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification
2023Open Access
Supplementary Table S3 from YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification
2023Open Access
Supplementary Table S2 from YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification
2023Open Access
Supplementary Table S1 from YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification
2023Open Access
Supplementary Table S3 from YES1 Is a Targetable Oncogene in Cancers Harboring <i>YES1</i> Gene Amplification
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Hirohisa Kishino(11), Norihiro Okada(11), Ying Cao(8), Jun Adachi(6), Masato Nikaido(6), Takahiro Yonezawa(5), Peter J. Waddell(5), Taka-aki Yano(4), William Martin(3), Takashi Miyata(3), Tetsuo Hashimoto(3), Hidetoshi Shimodaira(2), Bettina Stoebe(2), Tao Ma(2), Yang Zhong(2), Jian Wang(2), Jianquan Liu(2), Michael D. Sorenson(2), Healy Hamilton(2), R. Ewan Fordyce(2)